No black box warning on record for Valsartan And Hydrochlorothiazide

As of the latest FDA labeling reviewed, Valsartan And Hydrochlorothiazide (VALSARTAN AND HYDROCHLOROTHIAZIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Valsartan And Hydrochlorothiazide medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume depletion prior to initiation. (5.2) Observe for signs of fluid or electrolyte imbalance. (5.9) Monitor renal function and potassium in susceptible patients. (5.3, 5.7) Exacerbation or activation of systemic lupus erythematosus. (5.5) Acute angle-closure glaucoma. (5.8) 5.1 Fetal Toxicity Valsartan and hydrochlorothiazide can cause fetal harm

No black box warning on record for Valsartan And Hydrochlorothiazide

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume depletion prior to initiation. (5.2) Observe for signs of fluid or electrolyte imbalance. (5.9) Monitor renal function and potassium in susceptible patients. (5.3, 5.7) Exacerbation or activation of systemic lupus erythematosus. (5.5) Acute angle-closure glaucoma. (5.8) 5.1 Fetal Toxicity Valsartan and hydrochlorothiazide can cause fetal harm

Valsartan And Hydrochlorothiazide Black Box Warning

No black box warning on record for Valsartan And Hydrochlorothiazide

Other warnings & precautions

Valsartan And Hydrochlorothiazide Black Box Warning

No black box warning on record for Valsartan And Hydrochlorothiazide

Other warnings & precautions